Kendall Smith

Director/Miembro de la Junta en IMMUNEONCO BIOPHARMACEUTICALS (SHANGHAI) INC. .

84 años

Health Technology

Perfil

Kendall Arthur Smith has been an Independent Non-Executive Director at ImmuneOnco Biopharmaceuticals (Shanghai), Inc. since 2022.

Empresas	Cargo	Inicio
IMMUNEONCO BIOPHARMACEUTICALS (SHANGHAI) INC.	Director/Miembro de la Junta	14/06/2022

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Empresas privadas	1
ImmuneOnco Biopharmaceuticals (Shanghai) Co., Ltd. ImmuneOnco Biopharmaceuticals (Shanghai) Co., Ltd. Pharmaceuticals: MajorHealth Technology Operates as a early-stage biopharmaceutical company which develops and commercializes novel cancer immunotherapeutic products	Health Technology